American College of Toxicology (ACT) 2024 Annual Meeting
JW Marriott, Austin, Texas
November 17, 2024 - November 20, 2024The American College of Toxicology (ACT) Annual Meeting brought together a global community of toxicologists representing researchers across industry, regulatory agencies, research organizations, and academia. ATCC exhibited at the event to showcase our solutions for toxicology and toxicity testing. Check out our Exhibitor Hosted Session and browse our resources below to explore our renal, neural, airway, and skin models for applications like high-content screening, 3-D culture, spheroid culture, permeability assays, metabolic stability and survival studies, transport activity measurement, and more.
Did you miss us at booth#107 and want to speak to one of ATCC’s representatives about a product or service? Make an appointment with us so we can discuss your needs.
Join our Exhibitor Hosted Session
High-throughput, Predictive, and Reproducible Models for Hepatic, Cardiovascular, and Renal Toxicity Studies
Presenter: Sujoy Lahiri, PhD, Lead Scientist, Microphysiological Systems, ATCC
Date: Monday, November 18, 2024
Time: 12:00 PM – 12:55 PM
Location: Level 2, Room 201
Toxicologists are challenged by the lack of cell models that are physiologically relevant, reliable, and consistent between experiments. Here, we will discuss ATCC’s immortalized primary cells, which exhibit the growth and reproducibility of continuous cells, and the in vivo biologies of primary cells.
Primary human hepatocytes are considered the gold standard for in vitro liver models due to their high predictive value in drug metabolism and toxicity studies. They can provide early insights into how a drug will behave in the human body, potentially reducing the risk of adverse effects in clinical trials. ATCC hepatocytes are meticulously isolated and characterized to ensure the highest quality and performance for your drug development and toxicity testing needs. Try our HepatoXcell™ primary human hepatocytes and media today!
Learn moreLearn more about our toxicology portfolio
Get to the Heart of Your Toxicological Studies with Immortalized Primary Cells
This webinar discusses how modified primary cells are effective tools that provide tissue-relevant results and reproducibility for any cell-based assay, including toxicology assays.
More
Webinar
ATCC’s Toxicology Portfolio: Tools for Every Stage of Your Preclinical Drug Development Workstream Webinar
This webinar discusses how modified primary cells are effective tools that provide tissue-relevant results and reproducibility for any cell-based assay, including toxicology assays.
More
Webinar
Enable Renal ADME and Pharmaco-kinetics Studies Using Solute Carrier Transporter Cells
hTERT-immortalized primary cells are genetically modified such that the cells exhibit the growth characteristics of a continuous cell but maintain the physiology of a primary cell. This webinar focuses on hTERT-immortalized primary renal epithelial cells and provides application data to illustrate how these kidney models can easily be incorporated into your toxicity testing workflow.
MoreContact us today
Your ATCC sales representative stands ready to discuss your research needs and provide you with personalized care. Please complete our form to let us know how we can help, and we will start working on your needs right away.
